Zurueck zur Suche

Reporte zur Charge U7255AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

48Reporte angezeigt
0Todesfaelle
3Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 7 MA 5 CT 5 MI 4 CA 3 WA 3 UT 3 NY 2 VA 2 TN 2 KY 2 PA 2

VAERS 2582889

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

kritisch
Staat
NY
Alter
0,1
Geschlecht
M
Eingang
16.02.2023
Impfdatum
14.02.2023
Beginn
14.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Mobility decreased Respiratory arrest

Symptomtext

After receiving 2 month vaccines (patient was 60 days old) mother an aunt returned to the house. A few hours later they were giving him a bath and he turned red "from head to toe" and stopped breathing and moving x about 30 seconds. No physical stimulation or rescue breathing given. They called his name and he started to respond. Had a separate episode with similar symptoms and time course. One dose of Acetaminophen 2.5 ml (80mg) had been given prior. Family called virtual care and were told to observe. Did well overnight with no further episodes and drinking well. Never had fever or abnormal movements.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory arrest
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none. Mom was COVID + at time of delivery but infant COVID was negative.
Vorgeschichte
none
Andere Medikamente
one does Acetaminophen 2.5 ml (80mg) given
Allergien
none
Vorherige Impfungen
-

VAERS 2649564

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

schwer
Staat
CT
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
06.02.2023
Beginn
07.02.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyskinesia Febrile convulsion Pyrexia

Symptomtext

jerking movements of arms and legs lasting less than 1 min; Patient developed febrile seizure at 12 midnight on 2/7/23; tactile fever; This non-serious spontaneous safety report with reference number # 2649564 (VAERS ID-2649564-1) was received by a partner on 25-JUL-2023 and forwarded to agency on 28-JUL-2023 from a health care professional The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event of "jerking movements of arms and legs lasting less than 1 min, Patient developed febrile seizure at 12 midnight on 2/7/23 and tactile fever". Further information is not expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Teething
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2632804

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

schwer
Staat
NY
Alter
-
Geschlecht
F
Eingang
27.09.2023
Impfdatum
14.09.2022
Beginn
15.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electroencephalogram normal Facial paralysis Muscle twitching

Symptomtext

With one day baby developed a drooping eye & twitching of leg. The eye drooping lasted a week.; With one day baby developed a drooping eye & twitching of leg, the leg twitching was intermittent for 6 weeks; Electroencephalogram normal; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2632804-1. The original narrative from the sender is the following: With one day baby developed a drooping eye & twitching of leg. The eye drooping lasted a week & the leg twitching was intermittent for 6 weeks. Lab data included EEG (electroencephalogram) nl (normal) 05/04/2023. The causal relationship between Vaxelis and the events " With one day baby developed a drooping eye & twitching of leg. The eye drooping lasted a week; the leg twitching was intermittent for 6 weeks" was not reported, and causality between Vaxelis and " Electroencephalogram normal " was assessed as not applicable due to the nature of the reported event. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2606317

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

schwer
Staat
TX
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
07.03.2023
Beginn
08.03.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blood culture Computerised tomogram head normal Culture urine Electroencephalogram abnormal Infant irritability Crying Laboratory test Magnetic resonance imaging Seizure Metabolic function test Urine analysis

Symptomtext

Seizure episodes began on 03/11 taken to ER transferred to medical center where multiple episodes were recorded; Mom states that day of vaccines given 03/07 patient started getting fussy and this was unusual; Blood culture; Computerised Tomogram head normal; Culture urine; Electroencephalogram abnormal; Metabolic function test; Urine analysis; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2621576-1. The original narrative from the sender is the following: Patient mom states that day of vaccines given 03/07, patient started getting fussy and this was unusual for the patient. Seizure episodes began on 03/11, was taken to ER where he was then transferred to Medical Center where multiple episodes were recorded, pt was put on Keppra. The reporter did not provide an assessment of the causal relationship between Vaxelis and the events "Infant irritability and Seizure". No further information is expected. COMPANY COMMENT: Infant irritability and Seizure were assessed as serious due to hospitalization, whereas the events Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test, Urine analysis were assessed as non-serious. Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test and Urine analysis are unlisted, while Seizure and Infant irritability is listed as per the Reference Safety Information. Considering the current knowledge on the vaccine (Seizure is listed) and the short onset latency (within 2 days of vaccination), and despite the confounding factor (co-suspect vaccine) and the lack of information in this case (no medical history), the causal relationship between Vaxelis and Infant irritability and Seizure cannot be excluded and is assessed as related. Due to the nature of the events, the causal relationship between Vaxelis and Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test and Urine analysis were assessed as not applicable. This single individual case safety report does not modify the benefit/risk balance of this product. Therefore, no change in the label or other measures is recommended at this time. However, the company will continue to monitor all respective reports received and based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.; Sender's Comments: Infant irritability and Seizure were assessed as serious due to hospitalization, whereas the events Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test, Urine analysis were assessed as non-serious. Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test and Urine analysis are unlisted, while Seizure and Infant irritability is listed as per the Reference Safety Information. Considering the current knowledge on the vaccine (Seizure is listed) and the short onset latency (within 2 days of vaccination), and despite the confounding factor (co-suspect vaccine) and the lack of information in this case (no medical history), the causal relationship between Vaxelis and Infant irritability and Seizure cannot be excluded and is assessed as related. Due to the nature of the events, the causal relationship between Vaxelis and Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test and Urine analysis were assessed as not applicable. This single individual case safety report does not modify the benefit/risk balance of this product. Therefore, no change in the label or other measures is recommended at this time. However, the company will continue to monitor all respective reports received and based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2606317

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

schwer
Staat
TX
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
07.03.2023
Beginn
08.03.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blood culture Computerised tomogram head normal Culture urine Electroencephalogram abnormal Infant irritability Crying Laboratory test Magnetic resonance imaging Seizure Metabolic function test Urine analysis

Symptomtext

Seizure episodes began on 03/11 taken to ER transferred to medical center where multiple episodes were recorded; Mom states that day of vaccines given 03/07 patient started getting fussy and this was unusual; Blood culture; Computerised Tomogram head normal; Culture urine; Electroencephalogram abnormal; Metabolic function test; Urine analysis; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2621576-1. The original narrative from the sender is the following: Patient mom states that day of vaccines given 03/07, patient started getting fussy and this was unusual for the patient. Seizure episodes began on 03/11, was taken to ER where he was then transferred to Medical Center where multiple episodes were recorded, pt was put on Keppra. The reporter did not provide an assessment of the causal relationship between Vaxelis and the events "Infant irritability and Seizure". No further information is expected. COMPANY COMMENT: Infant irritability and Seizure were assessed as serious due to hospitalization, whereas the events Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test, Urine analysis were assessed as non-serious. Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test and Urine analysis are unlisted, while Seizure and Infant irritability is listed as per the Reference Safety Information. Considering the current knowledge on the vaccine (Seizure is listed) and the short onset latency (within 2 days of vaccination), and despite the confounding factor (co-suspect vaccine) and the lack of information in this case (no medical history), the causal relationship between Vaxelis and Infant irritability and Seizure cannot be excluded and is assessed as related. Due to the nature of the events, the causal relationship between Vaxelis and Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test and Urine analysis were assessed as not applicable. This single individual case safety report does not modify the benefit/risk balance of this product. Therefore, no change in the label or other measures is recommended at this time. However, the company will continue to monitor all respective reports received and based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.; Sender's Comments: Infant irritability and Seizure were assessed as serious due to hospitalization, whereas the events Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test, Urine analysis were assessed as non-serious. Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test and Urine analysis are unlisted, while Seizure and Infant irritability is listed as per the Reference Safety Information. Considering the current knowledge on the vaccine (Seizure is listed) and the short onset latency (within 2 days of vaccination), and despite the confounding factor (co-suspect vaccine) and the lack of information in this case (no medical history), the causal relationship between Vaxelis and Infant irritability and Seizure cannot be excluded and is assessed as related. Due to the nature of the events, the causal relationship between Vaxelis and Blood culture, Computerised tomogram Head normal, Culture urine, Electroencephalogram abnormal, Metabolic function test and Urine analysis were assessed as not applicable. This single individual case safety report does not modify the benefit/risk balance of this product. Therefore, no change in the label or other measures is recommended at this time. However, the company will continue to monitor all respective reports received and based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649563

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

schwer
Staat
TX
Alter
-
Geschlecht
M
Eingang
26.06.2023
Impfdatum
07.03.2023
Beginn
08.03.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Crying Seizure

Symptomtext

Multiple seizures/ Had his first seizure on 11MAR/ Had multiple seizure during the day in the hospital.; Crying a lot; This spontaneous serious safety report with reference number 2023SA096424 (Inquiry number 01547120) was received by a partner on 24-MAR-2023 and forwarded on 27-MAR-2023 from a other health care professional. A 4-month-old male patient had been vaccinated with the 1st dose of Vaxelis (Batch number U7255AA), on 07-MAR-2023 for immunization. No medical history was provided. Concomitant vaccination included Pneumococcal vaccine (PCP), (dose number unknown, Batch number unknown). On 08-MAR-2023, two days after receiving the vaccination with Vaxelis, the patient was reported to be crying a lot, from 08-MAR-2023 until 10-MAR-2023. Five days after the vaccination with Vaxelis, on 11-MAR-2023, the patient experienced his first seizure. On 13-MAR-2023 the patient was admitted to the emergency room and was reported to have multiple seizure during the stay in the hospital. No treatment information was provided. The patient was discharged from the hospital on 17-MAR-2023. At the time of this report, the outcome of the event was recovered/Resolved. Action taken with Vaxelis was unknown. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events of "Multiple seizures/ Had his first seizure on 11MAR/ Had multiple seizure during the day in the hospital" and "Crying a lot". Further information is expected. COMPANY COMMENT: Seizure is assessed as serious due to hospitalization. Crying was assessed as non-serious. Seizure and crying are listed for Vaxelis as per the Safety Information. Considering the current knowledge on Vaxelis (Seizure and Crying are listed as per safety information) and that the events appeared within one week after the vaccination and despite the lack of information (medical history, co-suspect vaccines), the causal relationship between Vaxelis and Seizure and Crying cannot be excluded and is assessed as related. This single individual case safety report does not modify the benefit/risk balance of this product. Therefore, no change in the label or other measures is recommended at this time. However, the company will continue to monitor all respective reports received and based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.; Sender's Comments: Seizure is assessed as serious due to hospitalization. Crying was assessed as non-serious. Seizure and crying are listed for Vaxelis as per the Safety Information. Considering the current knowledge on Vaxelis (Seizure and Crying are listed as per safety information) and that the events appeared within one week after the vaccination and despite the lack of information (medical history, co-suspect vaccines), the causal relationship between Vaxelis and Seizure and Crying cannot be excluded and is assessed as related. This single individual case safety report does not modify the benefit/risk balance of this product. Therefore, no change in the label or other measures is recommended at this time. However, the company will continue to monitor all respective reports received and based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
PNEUMOCOCCAL VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2577260

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

schwer
Staat
CT
Alter
0,8
Geschlecht
M
Eingang
07.02.2023
Impfdatum
06.02.2023
Beginn
07.02.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dyskinesia Febrile convulsion Influenza virus test negative Pyrexia Respiratory syncytial virus test negative SARS-CoV-2 test negative

Symptomtext

Patient developed febrile seizure at 12 midnight on 2/7/23. Dad reports tactile fever at that time and jerking movements of arms and legs lasting less than 1 min. He was evaluated in the Emergency Dept and no focal source of infection was identified. Dx home with dx of febrile seizure. He continues to have fever at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
Tested for flu/covid and RSV, all negative
Aktuelle Erkrankungen
teething
Vorgeschichte
none
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2653188

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
CA
Alter
-
Geschlecht
M
Eingang
28.12.2023
Impfdatum
27.06.2023
Beginn
27.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Rash

Symptomtext

Father reported that pt developed fever of 103 -104 deg F 3 hours after injection.Four days later, father reported that they called pt's PCP regarding fever, and provider advised to take pt to ER; Presented with generalized rash all over face and body.; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2653188-1. The original narrative from the sender is the following: "Father reported that pt developed fever of 103 -104 deg F 3 hours after injection. Father denied giving pt medication at home. Four days later, father reported that they called pt's PCP regarding fever, and provider advised to take pt to ER. Pt was taken to ER on 7/1/23, and pt was given prescription for Motrin and father was told fever should resolve in 2-3 days. Pt arrived to clinic on 7/5/23, pt with no fever (temp 98.8 tympanic) and in no apparent distress but presented with generalized rash all over face and body. Father denied taking pt back to ER for rash when it developed. Father reports that rash started after ER visit but does not know what day exactly. Advised father to take pt back to ER to get evaluated for rash, get blood tests, and treated for rash". The reporter assessed the casual relationship between Vaxelis and the events " Father reported that pt developed fever of 103 -104 deg F 3 hours after injection. Four days later, father reported that they called pt's PCP regarding fever", and "provider advised to take pt to ER and Presented with generalized rash all over face and body" as related. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2633089

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
CT
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
16.05.2023
Beginn
17.05.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Infant irritability Rash maculo-papular Irritability Rash macular Rash papular

Symptomtext

Afebrile but fussy.; Patient received vaccines ~ 20 hours later developed diffuse, macular rash with some papular areas; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS primary ID 2633089-1. The original narrative from the sender is as follows: Medical history included viral illness, 2 weeks prior. Concomitant medication included topical clotrimazole for unknown indication. Patient received vaccines ~ 20 hours later developed diffuse, macular rash with some papular areas. Afebrile but fussy. inconsistent with topical clotrimazole reaction that was put on neck. Not consistent with viral exanthem. Treatment of Benadryl PRN. The reporter did not provide an assessment of causal relationship between Vaxelis and the events, "afebrile but fussy" and "Patient received vaccines ~ 20 hours later developed diffuse, macular rash with some papular areas". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash maculo-papular
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Viral infection (2 weeks prior)
Vorgeschichte
-
Andere Medikamente
CLOTRIMAZOLE
Allergien
-
Vorherige Impfungen
-

VAERS 2630745

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
WA
Alter
-
Geschlecht
F
Eingang
27.09.2023
Impfdatum
08.05.2023
Beginn
09.05.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site induration Injection site warmth

Symptomtext

Area is warm to the touch and didn't seem to be painful when palpated; Pt has pink firm round area 3"X2.5" to R thigh where vaccine was administered; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2630745-1. The original narrative from the sender is the following: "Dad brought pt into clinic and this nurse was summoned to lobby. Pt was asleep on dads chest. Pt breathing normally with ygen saturation (02 sat)was at 98% RA, afebrile and HR=89. Pt aroused with physical touch. Pt has pink firm round area 3"X2.5" to R thigh where vaccine was administered. Area is warm to the touch and didn't seem to be painful when palpated. Dad states he has given pt Tylenol for comfort but pt does not complain of pain to area. Dad is not familiar with vaccines so he felt the need to have a nurse visualize area. This RN recommended cold pack to area, Pediatric Benadryl 12.5mg per bottle instructions and Tylenol for pain. Alert placed in chart for future immunization administration. Dad and pt left clinic without s/sx's distress.". The reporter did not provide the causal relationship between Vaxelis and the events, "Area is warm to the touch and didn't seem to be painful when palpated" and "Pt has pink firm round area 3"X2.5" to R thigh where vaccine was administered". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2629827

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
CT
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
08.05.2023
Beginn
08.05.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia SARS-CoV-2 test negative Streptococcus test negative

Symptomtext

Pyrexia; SARS-CoV-2 test negative; Streptococcus test negative; This spontaneous safety report, with reference number 2307USA002563 (VAERS Reference ID 2629827-1), was received by the partner on 06-JUL-2023 and forwarded on 10-JUL-2023, from a health professional. Follow-up non-significant information was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2629827-1. The reporter did not provide an assessment of causal relationship between Vaxelis and the events "Pyrexia". The causal relationship between Vaxelis and the events " Sars-COV-2 Test Negative" and " Streptococcus test negative" were assessed as not applicable due to the nature of the event. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Test Name: Temperature
Aktuelle Erkrankungen
Fever (2 weeeks); Teething
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2629827

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
CT
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
08.05.2023
Beginn
08.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia SARS-CoV-2 test negative Streptococcus test negative

Symptomtext

Pyrexia; SARS-CoV-2 test negative; Streptococcus test negative; This spontaneous safety report, with reference number 2307USA002563 (VAERS Reference ID 2629827-1), was received by the partner on 06-JUL-2023 and forwarded on 10-JUL-2023, from a health professional. Follow-up non-significant information was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2629827-1. The reporter did not provide an assessment of causal relationship between Vaxelis and the events "Pyrexia". The causal relationship between Vaxelis and the events " Sars-COV-2 Test Negative" and " Streptococcus test negative" were assessed as not applicable due to the nature of the event. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Test Name: Temperature
Aktuelle Erkrankungen
Fever (2 weeeks); Teething
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2627504

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
CA
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
01.05.2023
Beginn
02.05.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dermatitis Rash

Symptomtext

Dr. assessed the patient and stated Dermatitis Vs reaction to vaccines; Patient received vaccines on 5/1/2023 returned on 5/2/2023 with rash on body for 1 day.; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS primary ID 2627504-1. The original narrative from the sender is as follows: "Patient received vaccines on 5/1/2023 returned on 5/2/2023 with rash on body for 1 day. Dr. assessed the patient and stated Dermatitis VS reaction to vaccines. He prescribed Hydrocortisone 1% to apply BID. On 5/5/2023 I called parent, and she stated that rash is less." Treatment medication included Hydrocortisone 1% to apply BID (twice daily. The reporter did not provide an assessment of causal relationship between Vaxelis and the events "Dr. assessed the patient and stated Dermatitis Vs reaction to vaccines" and " Patient received vaccines on 5/1/2023 returned on 5/2/2023 with rash on body for 1 day". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2627504

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
CA
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
01.05.2023
Beginn
02.05.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dermatitis Rash

Symptomtext

Dr. assessed the patient and stated Dermatitis Vs reaction to vaccines; Patient received vaccines on 5/1/2023 returned on 5/2/2023 with rash on body for 1 day.; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS primary ID 2627504-1. The original narrative from the sender is as follows: "Patient received vaccines on 5/1/2023 returned on 5/2/2023 with rash on body for 1 day. Dr. assessed the patient and stated Dermatitis VS reaction to vaccines. He prescribed Hydrocortisone 1% to apply BID. On 5/5/2023 I called parent, and she stated that rash is less." Treatment medication included Hydrocortisone 1% to apply BID (twice daily. The reporter did not provide an assessment of causal relationship between Vaxelis and the events "Dr. assessed the patient and stated Dermatitis Vs reaction to vaccines" and " Patient received vaccines on 5/1/2023 returned on 5/2/2023 with rash on body for 1 day". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2621698

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
TX
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
23.01.2023
Beginn
24.01.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site swelling Keratosis pilaris

Symptomtext

On 01/26/2023 patient followed at our office ,bump was gone by then only keratosis pilaris was documented by Dr.; Mom noticed a bump on injection site on right leg on 01/24/2023; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS primary ID 2621698-1. The original narrative from the sender is as follows: Medical history included eczema. "Mom noticed a bump on injection site on Right leg on 01/24/2023, patient followed up in office on 01/26/2023 at our office, bump was gone by then only keratosis pilaris was documented by Dr." The reporter did not provide an assessment of causal relationship between Vaxelis and the events " Mom noticed a bump on injection site on right leg on 01/24/2023" and "On 01/26/2023 patient followed at our office, bump was gone by then only keratosis pilaris was documented by Dr." No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Eczema
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2621698

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
TX
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
23.01.2023
Beginn
24.01.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site swelling Keratosis pilaris

Symptomtext

On 01/26/2023 patient followed at our office ,bump was gone by then only keratosis pilaris was documented by Dr.; Mom noticed a bump on injection site on right leg on 01/24/2023; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS primary ID 2621698-1. The original narrative from the sender is as follows: Medical history included eczema. "Mom noticed a bump on injection site on Right leg on 01/24/2023, patient followed up in office on 01/26/2023 at our office, bump was gone by then only keratosis pilaris was documented by Dr." The reporter did not provide an assessment of causal relationship between Vaxelis and the events " Mom noticed a bump on injection site on right leg on 01/24/2023" and "On 01/26/2023 patient followed at our office, bump was gone by then only keratosis pilaris was documented by Dr." No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Eczema
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2651571

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
MA
Alter
0,5
Geschlecht
F
Eingang
30.06.2023
Impfdatum
28.06.2023
Beginn
30.06.2023
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Injection site erythema Pyrexia Rash

Symptomtext

Patient went to ER the day after the vaccine was administer for fever and rash. Follow up in our office for redness on right thigh today 6/30/23. Patient is being treated with antibiotic for cellulitis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649630

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
VA
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
12.01.2023
Beginn
13.01.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Coronavirus infection Coronavirus test positive Pyrexia

Symptomtext

Fever of 106 treated with Tylenol by mom, patient discharged home; Coronavirus infection; Coronavirus test positive; This non-serious case was received during monitoring on 12-APR-2023 with the following Primary ID 2559597-1. The original narrative from the sender is the following: Fever of 106 treated with Tylenol by mom, patient discharged home. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Fever of 106 treated with Tylenol by mom, patient discharged home, coronavirus infection, and coronavirus test positive". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Test Date: 20230113; Test Name: RP2 (positive coronavirus)
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649621

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
TX
Alter
-
Geschlecht
M
Eingang
27.06.2023
Impfdatum
24.01.2023
Beginn
24.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site swelling Rash

Symptomtext

Patient went to the office on 1/26 with a bump at the Vaxelis injection site; Rashes on right and left thigh; This non-serious spontaneous Safety Report, with reference number 2023SA031837, was received by partner on 26-JAN-2023 and forwarded on 27-JAN-2023 from other health professional. The reporter did not provide an assessment of the causal relationship between VAXELIS and the reported event "Patient went to the office on 1/26 with a bump at the Vaxelis injection site". Further information is expected. Significant Follow-up information was received by the partner on 24-MAR-2023 and forwarded on 27-MAR-2023, from other health professional. The case is maintained as non-serious. The reporter did not provide an assessment of the causal relationship between VAXELIS and the reported event "Patient went to the office on 1/26 with a bump at the Vaxelis injection site and Rashes on right and left thigh". Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2601986

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
UT
Alter
-
Geschlecht
M
Eingang
27.06.2023
Impfdatum
21.03.2023
Beginn
21.03.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
SYR / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Pain in extremity Peripheral swelling Skin warm Injection site erythema Injection site pain Injection site swelling Injection site warmth

Symptomtext

Right thigh is hot to touch, swollen, very red, painful; Right thigh is hot to touch, swollen, very red, painful; Right thigh is hot to touch, swollen, very red, painful; Right thigh is hot to touch, swollen, very red, painful; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary ID 2601986-1. The original narrative from the sender is as follows: Right thigh is hot to touch, swollen, very red, painful. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "Right thigh is hot to touch, swollen, very red, painful". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Otitis media
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2601986

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
UT
Alter
-
Geschlecht
M
Eingang
27.06.2023
Impfdatum
21.03.2023
Beginn
21.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Pain in extremity Peripheral swelling Skin warm Injection site erythema Injection site pain Injection site swelling Injection site warmth

Symptomtext

Right thigh is hot to touch, swollen, very red, painful; Right thigh is hot to touch, swollen, very red, painful; Right thigh is hot to touch, swollen, very red, painful; Right thigh is hot to touch, swollen, very red, painful; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary ID 2601986-1. The original narrative from the sender is as follows: Right thigh is hot to touch, swollen, very red, painful. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "Right thigh is hot to touch, swollen, very red, painful". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Otitis media
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2592367

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
MA
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
03.03.2023
Beginn
03.03.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pain Injection site rash Injection site reaction Rash erythematous Rash papular

Symptomtext

Red raised rash located around injection site; Red raised rash located around injection site; Red raised rash located around injection site; Injection site reaction; injection site pain; This case was retrieved during the monitoring on 12-APR-2023 with the following Primary ID 2592367-1. The original narrative from the sender is as follows: Red raised rash located around injection site, Injection site reaction, Injection site pain. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "Red raised rash located around injection site", Injection site reaction", "injection site pain. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
MUPIROCIN
Allergien
-
Vorherige Impfungen
-

VAERS 2592273

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
TN
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
02.03.2023
Beginn
02.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Vomiting projectile

Symptomtext

Patient developed projectile vomiting that would not stop; This case was retrieved during monitoring on 12-APR-2023 with the following Primary ID 2592273-1. The original narrative from the sender is as follows: Mom called on 03-MAR-2023 to report that patient developed projectile vomiting that would not stop. She was taken to ER and after 3 hours wait and no vomiting, she was taken home with no further evaluation. Mom called to inform us that she did not want patient to receive any further combo vaccines and wanted to give single vaccines once at a time. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "Patient developed projectile vomiting that would not stop". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting projectile
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2577947

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
NH
Alter
-
Geschlecht
M
Eingang
26.06.2023
Impfdatum
01.02.2023
Beginn
01.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood culture Culture urine Diarrhoea Full blood count Hypophagia Irritability Laboratory test Local reaction Pyrexia Tenderness Urine analysis

Symptomtext

Decreased oral intake; There was a little local reaction only slight tenderness; He had diarrhea; Was very fussy; Within 4 hours baby had a fever of 102.9; Full blood count; Laboratory Test; Urine analysis; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary ID 2577947-1. The original narrative from the sender is as follows: Within 4 hours baby had a fever of 102.9 and was very fussy. There was a little local reaction only slight tenderness. He had diarrhea and decreased oral intake. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events of "diarrhea, hypophagia, irritability, tenderness and pyrexia". The causal relationship between Vaxelis and the events of "full blood count, laboratory test and urine analysis" was not applicable due to the nature of the events. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2628684

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge U7255AA

mild
Staat
UT
Alter
2,0
Geschlecht
F
Eingang
08.05.2023
Impfdatum
19.04.2023
Beginn
01.04.2023
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Erythema Pruritus

Symptomtext

parent reports itchy and red but reports not painful. For location, parent reports legs. For duration, parent reports has noted for <1 week. For onset/timing, parent reports abrupt onset. For context, parent reports no new foods, no new detergents or skin products, no cold sxs, no insect bites, no plant exposure, and no one else with similar rash. For aggravating factors, parent reports nothing makes it worse. For associated symptoms, parent reports no fever, no cold symptoms, no nausea, no vomiting, no diarrhea, and no urinary symptoms. started on Zyrtec

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2559597

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
VA
Alter
0,3
Geschlecht
F
Eingang
13.01.2023
Impfdatum
12.01.2023
Beginn
13.01.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Coronavirus infection Coronavirus test positive Pyrexia

Symptomtext

Fever of 106 treated with Tylenol by mom, patient discharged home

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
RP2 - positive coronavirus OC43 1/13/23
Aktuelle Erkrankungen
found to be positive for coronavirus OC43 in ER, no diagnoses noted in MD report from 1/12/23 prior to vaccines being given
Vorgeschichte
congenital anomaly of the urinary tract proper
Andere Medikamente
none known
Allergien
NKA
Vorherige Impfungen
-

VAERS 2527843

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

mild
Staat
TX
Alter
0,3
Geschlecht
M
Eingang
09.12.2022
Impfdatum
08.12.2022
Beginn
08.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Allergy to vaccine Hypersensitivity Rash

Symptomtext

Encounter for vaccination: - AGE 6 WKS-4 YRS DTAP-IPV-HIB-HEP B (DIPH/TET/PERTUS, POLIOVIRUS, HAEMOPH INFL TYPE B, HEP B) VACCINE <VAXELIS> - AGE 0-18 YRS PCV-13 (PNEUMOCOCCAL, 13-VALENT) VACCINE <PREVNAR-13> - AGE 6 - 24 WKS ROTAVIRUS (MONOVALENT) VACCINE <ROTARIX> 12/08/2022 1620 Patient Care Technician was informed in the waiting area by the parent of the child he had developed a rash after the vaccines. Pt. was already discharged. Technician brought patient to an exam room. Charge Nurse was of the development of rash and orders. Pt. developed a rash on forehead, cheeks, and left forearm after administration of vaccines. Due to the allergic reaction to vaccines, pt received diphenhydramine (BENADRYL) 6.25 mg by mouth x1. Pt. alert, BBS present and clear. Pulse ox 99%, HR 138, RR 28. 12/08/2022 1636 Pt. with no distress. Rash had resolved. BBS present and clear.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2671543

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
KY
Alter
-
Geschlecht
F
Eingang
28.12.2023
Impfdatum
07.08.2023
Beginn
07.08.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient was behind on vaccines. The HIB in the Vaxelis was given too early. The HIB needed to be an 8wk interval; Patient did not have any issues with the injection per Mom; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2671543-1. The original narrative from the sender is the following: "Patient was in office for vaccines,RN gave Vaxelis to patient. Patient was behind on vaccines. The HIB in the Vaxelis was given too early. The HIB needed to be an 8wk interval. Patient mother was contacted and informed of error. Mother V/U. Patient did not have any issues with the injection per Mom. PCP was notified. Message left with Nurse. Mother notified to contact RN if issues accord. Due to the nature of the event, the casual relationship between Vaxelis and the events " Patient was behind on vaccines,the HIB in the Vaxelis was given too early, the HIB needed to be an 8wk interval ", and " Patient did not have any issues with the injection per Mom " was assessed as not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2671543

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
KY
Alter
-
Geschlecht
F
Eingang
28.12.2023
Impfdatum
07.08.2023
Beginn
07.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient was behind on vaccines. The HIB in the Vaxelis was given too early. The HIB needed to be an 8wk interval; Patient did not have any issues with the injection per Mom; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2671543-1. The original narrative from the sender is the following: "Patient was in office for vaccines,RN gave Vaxelis to patient. Patient was behind on vaccines. The HIB in the Vaxelis was given too early. The HIB needed to be an 8wk interval. Patient mother was contacted and informed of error. Mother V/U. Patient did not have any issues with the injection per Mom. PCP was notified. Message left with Nurse. Mother notified to contact RN if issues accord. Due to the nature of the event, the casual relationship between Vaxelis and the events " Patient was behind on vaccines,the HIB in the Vaxelis was given too early, the HIB needed to be an 8wk interval ", and " Patient did not have any issues with the injection per Mom " was assessed as not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2661260

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
TN
Alter
-
Geschlecht
M
Eingang
28.12.2023
Impfdatum
01.06.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Vaccine given outside of age range. Vaxelis is approved through age five, patient is six years old.; Patient has not had any s/s of adverse reaction; Vaccine given outside of age range. Vaxelis is approved through age five, patient is six years old; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2644045-1. The original narrative from the sender is the following: The case is classified as off label use due to Product use issue (product use in unapproved population). "Vaccine given outside of age range. Vaxelis is approved through age five, patient is six years old. No adverse s/s reported. Nurse called mother who states patient has not had any s/s of adverse reaction " The reporter assessed the causal relationship between Vaxelis and the events " Vaccine given outside of age range. Vaxelis is approved through age five, patient is six years old", " Patient has not had any s/s of adverse reaction", " Vaccine given outside of age range. Vaxelis is approved through age five, patient is six years old " as not applicable due to the nature of this event. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689352

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge u7255aa

gering
Staat
PA
Alter
-
Geschlecht
M
Eingang
02.10.2023
Impfdatum
01.04.2023
Beginn
01.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect product formulation administered Wrong product administered

Symptomtext

Incorrect product formulation administered; Wrong product administered; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID. The original narrative from the sender is the following: Patient was given Moderna Bivalent Pink cap, as first dose. No known symptoms. Patient will be revaccinated. Primary care provider called and advised parents of the incident. The causal relationship between Vaxelis and the events " Incorrect product formulation administered and wrong product administered." was assessed as not applicable due to the nature of the reported events. No further information is expected. is not working, added State under vaccine facility information and Reporter State.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2638479

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge u7255aa

gering
Staat
PA
Alter
-
Geschlecht
M
Eingang
02.10.2023
Impfdatum
01.04.2023
Beginn
01.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Underdose

Symptomtext

Patient was given Moderna Bivalent Pink cap, as first dose. No known symptoms.; Underdose; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2638479-1. The original narrative from the sender is the following: "Patient was given Moderna Bivalent Pink cap, as first dose. No known symptoms. Patient will be revaccinated. Primary care provider called and advised parents of the incident.". The assessment of causal relationship between Vaxelis and the events, " Patient was given Moderna Bivalent Pink cap, as first dose. No known symptoms. Patient will be revaccinated. Primary care provider called and advised parents of the incident" and "underdose" was not applicable. No further information is expected. Notes: Based on the available information, the events were not related to Vaxelis but to Covid-19 vaccine. Vaxelis should have been considered a concomitant, however the case was retrieved from VAERS and information was kept as reported in the form. Is not working, added State under vaccine facility information and Reporter State.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2688691

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
IN
Alter
0,5
Geschlecht
F
Eingang
29.09.2023
Impfdatum
16.03.2023
Beginn
16.03.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Livedo reticularis Peripheral swelling Skin warm

Symptomtext

On 9/28/23023 parent reported that both of patient's legs were swollen ,mottled and hot to touch after receiving 6m set on 3/16/23. Parent denied any other symptoms. Parents took infant to ER. Mom stated they were no help. Mother provided photo of patient's legs. Left leg appeared more swollen and mottled.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Livedo reticularis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Eczema
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2649300

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
AR
Alter
-
Geschlecht
F
Eingang
27.09.2023
Impfdatum
02.06.2023
Beginn
02.06.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age Product administration error

Symptomtext

PHN administered Vaxelis as a 4th dose of DTaP to a 5 year old patient. Vaxelis is not approved for 4th dose of DTaP or children over the age of 5 years.; PHN administered Vaxelis as a 4th dose of DTaP to a 5 year old patient. Vaxelis is not approved for 4th dose of DTaP or children over the age of 5 years.; PHN administered Vaxelis as a 4th dose of DTaP to a 5 year old patient. Vaxelis is not approved for 4th dose of DTaP or children over the age of 5 years; Mother verbalized no adverse reaction to vaccine administration; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2649300-1. The original narrative from the sender is the following: "PHN administered Vaxelis as a 4th dose of DTaP to a 5 year old patient. Vaxelis is not approved for 4th dose of DTaP or children over the age of 5 years. Clinic aware of error and clinic notified Regional Director, and Immunization Program nurse of the error. Per nurset, the dose can be considered valid with no revaccination necessary. On 6/7/23, Patient's mother was contacted by PHN and notified of error. Mother verbalized no adverse reaction to vaccine administration". The causal relationship between Vaxelis and the events, " PHN administered Vaxelis as a 4th dose of DTaP to a 5 year old patient. Vaxelis is not approved for 4th dose of DTaP or children over the age of 5 years" and "Mother verbalized no adverse reaction to vaccine administration" was assessed as not applicable due to the nature of the reported events. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2621601

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
WA
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
24.04.2023
Beginn
24.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product communication issue Wrong product administered

Symptomtext

Patient recieved Vaxelis instead of pentacel due to mishearing the doctor 's order; There was no obvious adverse event after vaccine administration; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2621601-1. The original narrative from the sender is the following: Concomitant medication included cholecalciferol 10mcg/mL - 1ml daily. "Patient received Vaxelis instead of Pentacel due to mishearing the doctor's order. There was no obvious adverse event after vaccine administration. Physician notified immediately." It was reported that Physician referenced the CDC to determine if the additional Hep B antigen vaccination would be harmful to baby and he concluded it would not. The causal relationship between Vaxelis and the events " Patient received Vaxelis instead of Pentacel due to mishearing the doctor 's order " and " There was no obvious adverse event after vaccine administration" were assessed as not applicable due to the nature of these reported events. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
CHOLECALCIFEROL
Allergien
-
Vorherige Impfungen
-

VAERS 2609152

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
MA
Alter
-
Geschlecht
F
Eingang
27.09.2023
Impfdatum
03.04.2023
Beginn
03.04.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Vaxelis was administered instead of DTaP (infanrix); This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2609152-1. The original narrative from the sender is as follows: It was reported that Vaxelis was administered instead of DTaP (Infantrix). The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "Vaxelis was administered instead of DTaP (infanrix)". Due to the nature of the event the causal relationship between Vaxelis and the events, "Vaxelis was administered instead of DTaP (infanrix)" is not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2664298

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
KS
Alter
1,6
Geschlecht
M
Eingang
01.08.2023
Impfdatum
01.08.2023
Beginn
01.08.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Syringe issue

Symptomtext

After administering the Vaxneuvance vaccine, I went to engage the safety needle and the syringe broke. The safety didn't engage, but I had moved it away from the patient and caregiver and nobody was injured.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syringe issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649643

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
04.01.2023
Beginn
04.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Off label use Wrong product administered

Symptomtext

Vaxelis was mistakenly administered instead at 11:45 AM; 5-year-old child; Patient currently not experiencing any adverse events; This case was retrieved during monitoring on 12-APR-2023 with the following Primary ID 2550238-1. The original narrative from the sender is as follows: Patient was due for her Influenza vaccine at the appointment. Vaxelis was mistakenly administered instead at 11:45AM. Mother was made aware of error at 11:48. Patient currently not experiencing any adverse reaction and will return at a later date for her Influenza vaccine. Mother aware of potential reaction types and voiced understanding. Due to the nature of the event, the causal relationship between Vaxelis and the events "Vaxelis was mistakenly administered instead at 11:45 AM" and "Patient currently not experiencing any adverse events" is not applicable. Off-label use added to the case due to Vaxelis being administered to a 5-year-old child. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
DAILY MULTIVITAMIN
Allergien
-
Vorherige Impfungen
-

VAERS 2649631

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge u7255aa

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
15.02.2023
Beginn
01.02.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Wrong product administered

Symptomtext

A MMRV WAS ADMINISTERED INSTEAD OF A MMR WHICH RESULTED IN THE PT RECEIVING TWO VARIVAX DOSES; A MMRV WAS ADMINISTERED INSTEAD OF A MMR WHICH RESULTED IN THE PT RECEIVING TWO VARIVAX DOSES; This case was retrieves during monitoring on 12-APR-2023 with the following Primary ID 2601724-1. The original narrative from the sender is as follows: A MMRV was administered instead of a MMR which resulted in the PT receiving two VARIVAX doses. Due to the nature of the events, the causal relationship between Vaxelis and the event "A MMRV was administered instead of a MMR which resulted in the PT receiving two VARIVAX doses" was not applicable. No further information is expected. Notes: Based on the available information, the events were not related to Vaxelis but to Varivax and MMR vaccine. Vaxelis should have been considered a concomitant, however the case was retrieved and information was kept as reported in the form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2556772

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
WA
Alter
-
Geschlecht
M
Eingang
27.06.2023
Impfdatum
09.01.2023
Beginn
09.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Patient was given influenza vaccine at his appointment on 1/9/2023 and he is 3 months old and it was not on schedule.; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary ID 2556772-1. The original narrative from the sender is the following: Patient was given Influenza vaccine at his appt on 1/9/2023 and he is 3 months old and it was not on schedule. He is not due to receive the vaccine until he is 6 months old. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Patient was given influenza vaccine at his appointment on 1/9/2023 and he is 3 months old and it was not on schedule.". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2591946

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
NJ
Alter
-
Geschlecht
M
Eingang
26.06.2023
Impfdatum
03.02.2023
Beginn
02.03.2023
Tage bis Beginn
27,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error Extra dose administered Vaccination site erythema

Symptomtext

Vaccination site erythema; Circumstance or information capable of leading to medication error; Extra dose administered; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary 2591946-1. The original narrative from the sender is as follows: Patient here for 12 month well child exam. Originally physician ordered Pentacel, Prevnar and Varivax but after chart review it was determined that child missed the 6 month well child exam and was in need of 3rd dose of Vaxelis. The consent form (paper) had been prepared based on the original orders of Pentacel, Prevnar and Varivax. When the medical assistant asked the MD to sign the order, the MD said (per the MA) we are giving VAXELIS, instead of Varivax. Per the MA, the MD watched the MA cross out VARIVAX and add VAXELIS as well as having the PENTACEL checked off. The MD then signed the order. MA administered the vaccines and upon documentation in the medical record, noted a different set of orders in the chart that DID NOT include the Pentacel but did include the Varivax. The MA did notify the physician and myself right away. The parent was notified of the event and was advised to monitor for increase in fever, irritability, or local reaction. I apologized for the experience and that I would be looking into how this occurred in spite of our careful attention to safety. I gave her my name to call for any additional questions. Parent did bring child to the ED for evaluation about 2 hrs after the incident. ED diagnosis of 'parental concern'. after the dual vaccinations received. Vital signs at that visit WNL with no fever. All other physical exam WNL except for '3 Vaccine sites notes with mild surrounding erythema but no tenderness'. The department on call physician was notified in case there were any further concern overnight which there were not. No subsequent calls were made to the office since then and no further ED evaluations noted. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2638478

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge u7255aa

gering
Staat
-
Alter
0,5
Geschlecht
M
Eingang
30.05.2023
Impfdatum
01.04.2023
Beginn
01.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered

Symptomtext

Patient was given Moderna Bivalent Pink cap, as first dose. No known symptoms. Patient will be revaccinated. Primary care provider called and advised parents of the incident.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2601724

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge u7255aa

gering
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
22.03.2023
Impfdatum
15.02.2023
Beginn
01.02.2023
Tage bis Beginn
-
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Wrong product administered

Symptomtext

A MMRV WAS ADMINISTERED INSTEAD OF A MMR WHICH RESULTED IN THE PT RECEIVING TWO VARIVAX DOSES

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2595630

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge U7255AA

gering
Staat
IA
Alter
1,3
Geschlecht
F
Eingang
13.03.2023
Impfdatum
13.03.2023
Beginn
13.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

NO reaction ROTA- aged out and wasn't needed but was given VAXELIS- combination vaccine given when single HIB and Dtap were what was needed. patient received extra Hep B and Polio (NO REACTION)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
na
Vorgeschichte
na
Andere Medikamente
na
Allergien
na
Vorherige Impfungen
-

VAERS 2583216

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7255AA

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
17.02.2023
Impfdatum
13.02.2023
Beginn
13.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AEs/no PQCs; VAXELIS and ROTATEQ were administered on 2/13/2023 after a temperature excursion.; This spontaneous report has been received from an office administrator, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. On 13-FEB-2023, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally (lot # 1892788 with expiration date: 02-DEC-2023) and diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection (lot # U7255AA with expiration date: 03-DEC-2024; route unknown), both for prophylaxis after a temperature excursion. The dose and strength were nor reported for suspect vaccines. No additional adverse events (AEs)/no product quality complaints (PQCs). Administered doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) experienced the temperature excursion above 9 degree Celsius (C) (10.92C) for 1 hour 0 minutes 0 seconds. No previous temperature excursions reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2550238

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
MI
Alter
5,0
Geschlecht
F
Eingang
04.01.2023
Impfdatum
04.01.2023
Beginn
04.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

Patient was due for her Influenza vaccine at the appointment. Vaxelis was mistakenly administered instead at 11:45AM. Mother was made aware of error at 11:48. Patient currently not experiencing any adverse reaction, and will return at a later date for her Influenza vaccine. Mother aware of potential reaction types and voiced understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
Daily multivitamin
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2539212

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
MA
Alter
1,3
Geschlecht
M
Eingang
21.12.2022
Impfdatum
21.12.2022
Beginn
21.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination error Wrong product administered

Symptomtext

Patient was ordered for 15 month vaccines: Infanrix, PCV13, HIB and Flu vaccine. This RN administered wrong vaccine and patient received Vexalis vaccine instead of Infanrix vaccine. RN immediately notified Dr. and nurse manager of error. RN called patient's mother and informed her of vaccine error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination error
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
none
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2525493

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7255AA

gering
Staat
MA
Alter
1,3
Geschlecht
M
Eingang
07.12.2022
Impfdatum
07.12.2022
Beginn
07.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Vaxelis vaccine given accidentally instead of Dtap vaccine. Pt parent informed of error. Pt is doing well. No adverse reactions as of yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
nka
Vorherige Impfungen
-